Tags: Goldman Sachs
CVS Health to buy Target's pharmacy business for $1.9 billion
Drugstore operator CVS Health Corp (CVS.N) will buy Target Corp's (TGT.N) pharmacies and clinics in a $1.9 billion deal that should help it bargain with drug makers for lower prices, while freeing Target from a costly business where it struggled to make a profit.
Oil prices rise on U.S. stock draw, strong Japan data
Crude oil prices bounced back on Wednesday from steep falls in the previous session as industry data showed that U.S. crude stocks fell more than expected last week.
Goldman cuts crude outlook and oil company forecasts
Goldman Sachs has cut its long-term crude oil price forecasts and recommended investors sell shares in two major oil companies, saying that improved U.S. shale efficiency and higher production from OPEC will more than cover future demand.
Syngenta rejects $45 billion Monsanto takeover offer
Agrochemicals firm Syngenta on Friday rejected a $45 billion takeover offer from Monsanto, saying the offer undervalued the Swiss firm and did not fully take into account regulatory risks.




